What are GeneDx Holdings's total assets?

GeneDx Holdings (WGS) holds $506.3M in total assets, up 13.4% year over year.

How much debt does GeneDx Holdings have?

GeneDx Holdings carries $96.7M in total debt against $254.1M of shareholders' equity, a debt-to-equity ratio of 0.38.

How much cash does GeneDx Holdings have?

GeneDx Holdings holds $94.9M in cash and equivalents.

Can GeneDx Holdings cover its short-term obligations?

Its current ratio is 3.09 — current assets exceed current liabilities.

Where does GeneDx Holdings's balance sheet data come from?

Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

GeneDx Holdings WGS Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$105.99M+23.0%	$86.2M-14.4%	$100.67M-27.2%	$138.3M-65.6%
Short-term investments	$66.29M+18.4%	$55.97M+83.7%	$30.47M—	$0—
Restricted cash	$992K+0.2%	$990K+0.3%	$987K-92.7%	$13.47M—
Accounts receivable, net	$229.32M+427%	$43.48M+36.3%	$31.91M-81.1%	$168.75M+59.7%
Inventories	$49.11M+13.3%	$43.36M+3.3%	$41.99M-69.1%	$135.76M+7.1%
Total current assets	$268.29M+35.5%	$197.97M+8.6%	$182.34M-14.2%	$212.62M-56.0%
Property and equipment, net	$45.69M+38.9%	$32.89M+1.3%	$32.48M-37.0%	$51.53M-17.8%
Accumulated depreciation	$25.52M+25.7%	$20.31M-56.3%	$46.45M-54.2%	$101.46M+95.5%
Operating lease right-of-use assets	$23.41M-8.6%	$25.61M-4.8%	$26.9M-17.9%	$32.76M—
Goodwill	$13.52M—	$0—	——	——
Intangible assets, net	$168.48M+6.2%	$158.6M-8.1%	$172.63M-7.5%	$186.65M—
Deferred tax assets	$757K-21.6%	$965K-38.1%	$1.56M-41.3%	$2.66M—
Other non-current assets	$4.32M+0.2%	$4.31M-2.4%	$4.41M-32.0%	$6.49M-6.4%
Total assets	$523.71M+24.9%	$419.38M+0.1%	$418.76M-14.7%	$490.94M-11.4%
Accounts payable	$2.46M-69.1%	$7.95M-22.3%	$10.24M-77.8%	$46.02M+3.0%
Accrued expenses	$46.86M+129%	$20.5M+68.7%	$12.15M-40.2%	$20.31M-39.2%
Current portion of long-term debt	$4.54M+275%	$1.21M+144%	$497K-89.5%	$4.75M—
Total current liabilities	$108.91M+98.7%	$54.82M-6.8%	$58.82M-59.2%	$144.3M+42.5%
Long-term debt	$48.18M-7.2%	$51.91M-1.5%	$52.69M+743%	$6.25M-43.2%
Other non-current liabilities	$1.64M-70.3%	$5.52M-62.5%	$14.74M-38.7%	$24.02M+9.6%
Total liabilities	$2.67M-98.5%	$174.13M-8.7%	$190.74M-19.6%	$237.24M+42.9%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	1B+49,999,900%	2K0.0%	2K+100%	1K-95.8%
Additional paid-in capital	$1.68B+5.3%	$1.6B+4.5%	$1.53B+10.9%	$1.38B+43.0%
Retained earnings	-$1.37B-1.6%	-$1.35B-4.0%	-$1.3B-15.6%	-$1.12B-95.4%
Accumulated other comprehensive income (loss)	$936K+12.8%	$830K+95.3%	$425K—	$0—
Total stockholders' equity	$308.18M+25.7%	$245.25M+7.6%	$228.02M-10.1%	$253.71M-34.6%
Total liabilities and stockholders' equity	$523.71M+24.9%	$419.38M+0.1%	$418.76M-14.7%	$490.94M-11.4%
Short- term Investments	$66.29M+18.4%	$55.97M+83.7%	$30.47M—	$0—
Other current assets	$1.51M+40.0%	$1.08M-44.9%	$1.96M-69.4%	$6.39M+68.1%
Deferred Tax Assets and Other Non-Current Assets	$4.32M+0.2%	$4.31M-2.4%	$4.41M-40.2%	$7.39M+6.6%
Finite Lived Intangible Assets - Gross	——	——	——	——
Net Investment in Lease	$23.41M-8.6%	$25.61M-4.8%	$26.9M-17.9%	$32.76M—
Intangible assets — net	——	——	——	——
Other intangible assets—net	$168.48M+6.2%	$158.6M-8.1%	$172.63M-7.5%	$186.65M—
Operating lease right-of-use assets	$23.41M-8.6%	$25.61M-4.8%	$26.9M-17.9%	$32.76M—
Other non-current assets	$4.32M+0.2%	$4.31M-2.4%	$4.41M-40.2%	$7.39M+6.6%
Property, plant and equipment, net	$45.69M+38.9%	$32.89M+1.3%	$32.48M-37.0%	$51.53M-17.8%
Property, plant and equipment at cost	$71.21M—	——	——	$152.99M+33.5%
Operating Lease Right-of-Use Assets in Other Assets	$23.41M-8.6%	$25.61M-4.8%	$26.9M-17.9%	$32.76M—
Software and Technology Licenses, Net	$4.32M+0.2%	$4.31M-2.4%	$4.41M-40.2%	$7.39M+6.6%
Other Commercial Liabilities	$44.66M+259%	$12.44M+2.4%	$12.15M-40.2%	$20.31M+1.0%
Accounts payable and other current liabilities (Note 11)	$57.65M+86.1%	$30.98M-17.3%	$37.46M-55.9%	$84.88M+31.0%
Accrued Liabilities, Current	$44.66M+259%	$12.44M+2.4%	$12.15M-40.2%	$20.31M+1.0%
Short-term lease liabilities	$4.4M+32.0%	$3.34M-8.5%	$3.65M-40.4%	$6.12M—
Other accrued liabilities	$46.86M+129%	$20.5M—	——	$49.71M+48.9%
Operating Lease Liability Payments Due	——	——	——	——
Settlement Liabilities (Current)	$5.56M—	——	$25K—	——
Contingent Consideration Liability (Non-Current)	$1.57M—	$0—	——	$1.6M-84.4%
Total debt	$113.17M-3.6%	$117.38M-2.0%	$119.77M+55.3%	$77.13M+135%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	29.2M+4.4%	28M+7.8%	26M+121%	11.8M-95.1%
Convertible Preferred Stock Authorized Shares	1M0.0%	1M0.0%	1M0.0%	1M—
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$3K+50.0%	$2K0.0%	$2K+100%	$1K-95.8%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——
Warrants and Rights Outstanding	——	——	——	666.5K0.0%
Cumulative Cost Basis	$71.21M—	——	——	$152.99M+33.5%
Accrued bonuses	$29.64M+82.5%	$16.24M+30.3%	$12.47M+47.9%	$8.43M-37.8%
Accrued severance	$771K+3.4%	$746K-59.7%	$1.85M-61.2%	$4.77M—
Business Combination, Contingent Consideration, Liability	$1.57M—	——	——	$0-100%
Class of Warrant or Right, Outstanding	——	——	——	$666.52K0.0%
Target share price of warrants or rights for redemption (in dollars per share)	——	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$1B0.0%	$1B0.0%	$1B0.0%	$1B+163%
Common stock, shares issued (in shares)	$29.25M+4.4%	$28.02M+7.8%	$25.98M+121%	$11.77M-95.1%
Common Stock, Shares, Outstanding	$29.25M+4.4%	$28.02M+7.8%	$25.98M+121%	$11.77M-95.1%
Deferred Finance Costs Noncurrent Net	——	——	——	——
Deferred income taxes	$757K-21.6%	$965K-38.1%	$1.56M-41.3%	$2.66M—
Cost not yet recognized	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Amortization	——	——	——	——
Finite-Lived Intangible Assets, Accumulated Impairment	——	——	——	——
Gross Carrying Amount	——	——	——	——
Long-term lease liabilities	$56.05M-8.0%	$60.92M-3.2%	$62.94M+4.9%	$60.01M—
Lessee Operating Lease Liability Payments Due	——	——	——	——
Other	$71K—	$0—	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$1M0.0%	$1M0.0%	$1M0.0%	$1M—
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Prepaid expenses	$7.17M-3.4%	$7.43M-14.1%	$8.64M-26.9%	$11.82M-38.3%
Settlement Liabilities, Current	$5.56M—	——	$25K—	——
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price	——	——	——	——
Third party payor reserves, short-term	$4.97M-53.1%	$10.59M—	——	$17M—
Short-term warrant liability	$1.1M—	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about GeneDx Holdings.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are GeneDx Holdings's total assets?: GeneDx Holdings (WGS) holds $506.3M in total assets, up 13.4% year over year.
How much debt does GeneDx Holdings have?: GeneDx Holdings carries $96.7M in total debt against $254.1M of shareholders' equity, a debt-to-equity ratio of 0.38.
How much cash does GeneDx Holdings have?: GeneDx Holdings holds $94.9M in cash and equivalents.
Can GeneDx Holdings cover its short-term obligations?: Its current ratio is 3.09 — current assets exceed current liabilities.
Where does GeneDx Holdings's balance sheet data come from?: Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.